Abstract:The demonstration of metabolically active brown adipose tissue (BAT) in humans primarily using positron emission tomography coupled to computed tomography (PET/CT) with the glucose tracer 18-fluorodeoxyglucose (18FDG) has renewed the interest of the scientific and medical community in the possible role of BAT as a target for the prevention and treatment of obesity and type 2 diabetes (T2D). Here, we offer a comprehensive review of BAT energy metabolism in humans. Considerable advances in methods to measure BAT energy metabolism, including nonesterified fatty acids (NEFA), chylomicron-triglycerides (TG), oxygen, Krebs cycle rate, and intracellular TG have led to very good quantification of energy substrate metabolism per volume of active BAT in vivo. These studies have also shown that intracellular TG are likely the primary energy source of BAT upon activation by cold. Current estimates of BAT's contribution to energy expenditure range at the lower end of what would be potentially clinically relevant if chronically sustained. Yet, 18FDG PET/CT remains the gold-standard defining method to quantify total BAT volume of activity, used to calculate BAT's total energy expenditure. Unfortunately, BAT glucose metabolism better reflects BAT's insulin sensitivity and blood flow. It is now clear that most glucose taken up by BAT does not fuel mitochondrial oxidative metabolism and that BAT glucose uptake can therefore be disconnected from thermogenesis. Furthermore, BAT thermogenesis is efficiently recruited upon repeated cold exposure, doubling to tripling its total oxidative capacity, with reciprocal reduction of muscle thermogenesis. Recent data suggest that total BAT volume may be much larger than the typically observed 50-150 ml with 18FDG PET/CT. Therefore, the current estimates of total BAT thermogenesis, largely relying on total BAT volume using 18FDG PET/CT, may underestimate the true contribution of BAT to total energy expenditure. Quantification of the contribution of BAT to energy expenditure begs for the development of more integrated whole body in vivo methods.

Anatomical and Functional Assessment of Brown Adipose Tissue by Magnetic Resonance Imaging

Molecular Imaging of Brown Adipose Tissue Mass

Non-invasive mapping of brown adipose tissue activity with magnetic resonance imaging

Non-invasive Imaging Methods for Brown Adipose Tissue Detection and Function Evaluation.

A synopsis of brown adipose tissue imaging modalities for clinical research

Brown Adipose Tissue Mapping in Rats with Combined Intermolecular Double‐quantum Coherence and Dixon Water–fat MRI

Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT

Brown Adipose Tissue Energy Metabolism in Humans

Detection of brown adipose tissue and thermogenic activity in mice by hyperpolarized xenon MRI

Brown Adipose Tissue Response Dynamics: In Vivo Insights with the Voltage Sensor 18F-Fluorobenzyl Triphenyl Phosphonium

Accurate quantification of brown adipose tissue mass by xenon-enhanced computed tomography

ADIPOSITY-RELATED CANCER AND FUNCTIONAL IMAGING OF BROWN ADIPOSE TISSUE

Non-invasive metabolic imaging of brown adipose tissue

Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts

Absolute thermometry of human brown adipose tissue by magnetic resonance with laser polarized 129Xe

[Brown Adipose Tissue in Human and Its Potential Physiological Significance].

Quantification of Fat Concentration and Vascular Response in Brown and White Adipose Tissue of Rats by Spectral CT Imaging

Brown Adipose Tissue—A Translational Perspective

Measuring Brown Fat Using MRI and Implications in the Metabolic Syndrome

Comparison of BMIPP-SPECT/CT to 18FDG-PET/CT for Imaging Brown or Browning Fat in a Preclinical Model

Identification and characterization of distinct brown adipocyte subtypes in C57BL/6J mice